| Value | ₹6.48 Cr |
|---|
NSE filing, NSE: CARBORUNIV. Summary written from the filing by ALFA Finder's alert engine.
Carborundum Universal Ltd: key numbers
- Share price
- ₹1,059.70
- Market cap
- ₹20,188 Cr
- Revenue (annual)
- ₹5,206 Cr
- Net profit (annual)
- ₹194.7 Cr
- P/E (TTM)
- 96.5×Sector 52.2×
- Promoter holding
- 38.84%-0.05% QoQ
- FII holding
- 11.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Carborundum Universal Ltd
All →Carborundum Universal Other Announcement
Carborundum Universal Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory reporting requirements.
Carborundum Universal Board Meeting Date
Carborundum Universal has scheduled a board meeting for November 2, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Carborundum Universal Other Announcement
Carborundum Universal Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, provided by its RTA, KFin Technologies Limited.
Carborundum Universal Employee Stock Options
Carborundum Universal Limited allotted 4,750 equity shares following the exercise of stock options under its ESOP Plan 2016.
Carborundum Universal Acquisition Worth ₹28.78 Cr
Carborundum Universal will invest ₹28.78 Crore in its wholly-owned subsidiary, CUMI International Limited. This capital infusion supports the closure of a German subsidiary.
- Value
- ₹28.78 Cr
Carborundum Universal Merger & Restructuring Worth ₹28.78 Cr
Carborundum Universal infused USD 3 million (approx. Rs. 28.78 Crore) into its wholly-owned subsidiary, CUMI International Limited, to fund its subsidiary's closure.
- Value
- ₹28.78 Cr
Other acquisition announcements
All →Laurus Labs Acquisition Worth ₹32.5 Cr
Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.
- Value
- ₹32.50 Cr
Laurus Labs Acquisition Worth ₹35.63 Cr
Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.
- Value
- ₹35.63 Cr
Raghav Productivity Enhancers Acquisition
RPEL acquires 80% of RPEL TRLK Silicatech Private Limited for a nominal cash subscription. The target manufactures silica ramming mass and other refractories in India.
Container Corporation of India Acquisition Worth ₹485.9 Cr
CONCOR placed an order with Braithwaite & Co for 24 rakes of BLSS wagons. The deal, including GST, values at Rs.485.93 Crores.
- Value
- ₹485.9 Cr
- Execution
- Delivery by 20.06.2028
- BLSS wagons (fleet)
- 24.0 rakes
Embassy Developments Acquisition Worth ₹32.65 Cr
Embassy Developments signed an SPA to acquire 50% of Embassy Columbia Pacific ASL for ₹32.65 Crore. The JV will become wholly owned upon closing by December 2026.
- Value
- ₹32.65 Cr
- Execution
- Within the current quarter ending on December 31, 2026
MosChip Technologies Acquisition Worth ₹266.7 Cr
MosChip will acquire Vayavya Labs for Rs.266.71 Crore in cash and shares. Completion awaits RBI and exchange approvals and shareholder approval of a preferential issue.
- Value
- ₹266.7 Cr
- Execution
- Within 15 days of the later of receipt of all requisite approvals or shareholder approval of the preferential issue to VLPL sellers